INTRAROSA (Theramex Australia Pty Ltd)
Product name
INTRAROSA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
150 (175 working days)
Registration type
NCE/NBE
Indication
INTRAROSA is indicated for the treatment of vulvar and vaginal atrophy in postmenopausal women having moderate to severe symptoms.